These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21705067)

  • 21. Recent progress in the treatment of diabetic nephropathy: importance of strict glycemic control on the regression of diabetic nephropathy.
    Kawamori R; Kamado K; Kamada T
    J Diabet Complications; 1991; 5(2-3):88-90. PubMed ID: 1770063
    [No Abstract]   [Full Text] [Related]  

  • 22. [Intensive glycemia control of type-2 diabetes mellitus: a real A(D)VANCe or a deep dis(ACCORD)?].
    Lambiel J; Fumeaux T
    Rev Med Suisse; 2008 Aug; 4(166):1734. PubMed ID: 18777740
    [No Abstract]   [Full Text] [Related]  

  • 23. Lack of correlation of glycosylated haemoglobin level with the duration of diabetes or diabetic angiopathy.
    Blickle JF; North ML; Brogard JM; Reville P
    Ann Med Interne (Paris); 1986; 137(3):264-6. PubMed ID: 3767198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The level of glycosylated hemoglobin A1c in the erythrocytes of patients with diabetic angio- and polyneuropathies].
    Karabun PM
    Probl Endokrinol (Mosk); 1989; 35(5):33-7. PubMed ID: 2587522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucose control and cardiovascular complications: the VA Diabetes Trial.
    Duckworth WC; McCarren M; Abraira C;
    Diabetes Care; 2001 May; 24(5):942-5. PubMed ID: 11347758
    [No Abstract]   [Full Text] [Related]  

  • 26. Diabetic microangiopathy and blood viscosity changes after pancreas and kidney transplantation.
    Abendroth D; Landgraf R; Pfeiffer M; Reininger J; Seidel D; Land W
    Transplant Proc; 1994 Apr; 26(2):491-2. PubMed ID: 8171519
    [No Abstract]   [Full Text] [Related]  

  • 27. Threshold of HbA1c for the effect of hyperglycemia on the risk of diabetic microangiopathy.
    Danne T; Weber B; Dinesen B; Mortensen HB
    Diabetes Care; 1996 Feb; 19(2):183. PubMed ID: 8718448
    [No Abstract]   [Full Text] [Related]  

  • 28. Dietary predictors of arterial stiffness in a cohort with type 1 and type 2 diabetes.
    Petersen KS; Keogh JB; Meikle PJ; Garg ML; Clifton PM
    Atherosclerosis; 2015 Feb; 238(2):175-81. PubMed ID: 25528424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrinogen and diabetes mellitus: is it time for intervention trials?
    Ceriello A
    Diabetologia; 1997 Jun; 40(6):731-4. PubMed ID: 9222655
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevalence of macro- and microvascular disease as related to glycosylated hemoglobin in type I and II diabetic subjects. An epidemiologic study in Denmark.
    Nielsen NV; Ditzel J
    Horm Metab Res Suppl; 1985; 15():19-23. PubMed ID: 3908278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Incidence and type of dyslipidemia in a diabetic population].
    Urbani A; Repeti M; Barbaro D; Bassano G; Bernini F; Boldrin M; Crestini AM; Lombardo M; Marino O
    Clin Ter; 1994 Mar; 144(3):237-40. PubMed ID: 8181220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular factors in diabetic neuropathy: comment.
    Simpson LO
    Diabetologia; 1995 Jul; 38(7):872-3. PubMed ID: 7556993
    [No Abstract]   [Full Text] [Related]  

  • 33. A1c and mortality: an unexpected relationship in patients with advanced heart failure.
    Tayek JA
    Am Heart J; 2006 Jul; 152(1):e5; author reply e7. PubMed ID: 16824822
    [No Abstract]   [Full Text] [Related]  

  • 34. Diabetes and the endocrine heart.
    Christoffersen C; Hunter I; Jensen AL; Goetze JP
    Eur Heart J; 2007 Oct; 28(20):2427-9. PubMed ID: 17872916
    [No Abstract]   [Full Text] [Related]  

  • 35. The prevalence, detection, and epidemiological correlates of peripheral vascular disease: a comparison of diabetic and non-diabetic subjects in an English community.
    Walters DP; Gatling W; Mullee MA; Hill RD
    Diabet Med; 1992 Oct; 9(8):710-5. PubMed ID: 1395462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Burden of Cardiovascular Risk Factors Over Time and Arterial Stiffness in Youth With Type 1 Diabetes Mellitus: The SEARCH for Diabetes in Youth Study.
    Urbina EM; Isom S; Bell RA; Bowlby DA; D'Agostino R; Daniels SR; Dolan LM; Imperatore G; Marcovina SM; Merchant AT; Reynolds K; Shah AS; Wadwa RP; Dabelea D;
    J Am Heart Assoc; 2019 Jul; 8(13):e010150. PubMed ID: 31213111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comment on: McClung JA, Naseer N, Saleem M et al (2005) circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA1c. Diabetologia 48:345-350.
    Thanopoulou A; Karamanos B; Archimandritis A
    Diabetologia; 2005 Dec; 48(12):2687; author reply 2688. PubMed ID: 16273347
    [No Abstract]   [Full Text] [Related]  

  • 38. Toward risk factor control for all patients with diabetes.
    Whitehouse F
    Diabetes Care; 1992 Nov; 15(11):1818-20. PubMed ID: 1468321
    [No Abstract]   [Full Text] [Related]  

  • 39. Platelet hyper- and hypoaggregability in different microangiopathic complications of diabetes mellitus.
    Szénási P; Tóth L; Romics L; Kammerer L
    Acta Diabetol Lat; 1988; 25(1):7-12. PubMed ID: 3407379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes.
    Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():3-8. PubMed ID: 24034513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.